SHR-4506
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SHR-4506, covering 2025-08-26 to 2025-08-26. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Study of SHR-4506 Injection in Patients With Malignant Tumors [Phase 1]